To include your compound in the COVID-19 Resource Center, submit it here.

Incyte buying Ariad's European operations, Iclusig rights

Incyte Corp. (NASDAQ:INCY) will acquire the European operations of Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), including exclusive rights to leukemia drug Iclusig ponatinib in the EU and 22 other countries including Switzerland, Turkey and

Read the full 322 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE